dsip umich The University of Michigan Doubled Down on D.E.I. What Went Wrong? Welcome to D-SIP 2025-Project Showcase
Description
263 KeenoyBMMoorkensGVertommenJDe LeeuwI
Competing Interests The authors declare no competing interests
From the viewpoint of neurotransmitters and neurotransmission for the brain, cerebral, cerebellar, hypothalamus, and hippocampus lesions, and cytoprotection as innate background for the interconnected pleiotropic beneficial effect, there is growing evidence that BPC 157 therapy can counteract the occlusion/occlusion-like syndromes [40,41,42,43,47,48,49,50,51,52,53,54,55,56]
42:110
